1. Home
  2. WKHS vs LEXX Comparison

WKHS vs LEXX Comparison

Compare WKHS & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$5.38

Market Cap

17.4M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.75

Market Cap

17.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
LEXX
Founded
2007
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
17.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WKHS
LEXX
Price
$5.38
$0.75
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$21.00
$1.50
AVG Volume (30 Days)
225.4K
1.5M
Earning Date
11-10-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$705,923.00
Revenue This Year
$92.70
$13.35
Revenue Next Year
$34.00
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
16.73
52.05
52 Week Low
$5.01
$0.46
52 Week High
$118.50
$2.30

Technical Indicators

Market Signals
Indicator
WKHS
LEXX
Relative Strength Index (RSI) 58.28 43.75
Support Level $5.20 $0.46
Resistance Level $6.00 $0.72
Average True Range (ATR) 0.40 0.09
MACD -0.18 0.02
Stochastic Oscillator 35.35 93.07

Price Performance

Historical Comparison
WKHS
LEXX

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: